@article{CCO1265,
author = {Rintaro Noro and Tesshi Yamada},
title = {Drifting EGFR mutation},
journal = {Chinese Clinical Oncology},
volume = {2},
number = {1},
year = {2012},
keywords = {},
abstract = {It is generally accepted that somatic mutation in the EGFR gene can serve as a biomarker for predicting the efficacy of treatment with epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKI) in patients with non-small cell lung cancer (NSCLC).},
issn = {2304-3873}, url = {https://cco.amegroups.org/article/view/1265}
}